A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong ...

Patients relapsing within three months post-CAR T-cell therapy have lower response rates to BsAb therapy compared to those relapsing after six months. Elevated LDH levels and higher international ...

A. Keith Stewart, MB, ChB: At the time of progression, we assume that drug resistance has emerged within the myeloma clone, and that can sometimes make it difficult to use the same drug or same class ...

Led by Professor Anskar Leung Yu-hung, a HKUMed study shows that the combined use of the FLT3 inhibitor Quizartinib and the ...

In a study published in the journal Blood today, a team of oncologists reported that therapies that engage T cells, including bispecific antibodies and other CAR-T cell therapies, appear to have the ...

A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can ...

Recovery from addiction is a challenging journey, filled with both triumphs and setbacks. For individuals seeking long-term sobriety, relapse can be a disheartening reality. However, recent findings ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...